Zobrazeno 1 - 5
of 5
pro vyhledávání: ''
Autor:
Masafumi Shimoda, Naofumi Kagara, Tomonori Tanei, Atsushi Shimomura, Yasuto Naoi, Saki Matsui, Kenzo Shimazu, Seung Jin Kim, Chieko Mishima, Shinzaburo Noguchi
Publikováno v:
SpringerPlus
The aim of the present study was to investigate the promoter methylation status of TRIM9 in breast cancer and to determine the presence of TRIM9-methylated circulating tumor DNA (ctDNA) in plasma. Bisulfite sequencing with a next generation sequencer
Autor:
Dorothy Long Parma, Daniel C. Hughes, Sagar Ghosh, Rong Li, Rose A. Treviño-Whitaker, Amelie G. Ramirez, Susan M. Ogden
Publikováno v:
SpringerPlus
Yoga-based exercise has proven to be beneficial for practitioners, including cancer survivors. This study reports on the effect on inflammatory biological markers for 20 breast cancer survivors who participated in a six-month yoga-based (YE) exercise
Autor:
Gregory R. Pond, Huijun Zhao, Eitan Amir, Lisa Vandermeer, Christina L. Addison, Mark Clemons, Sasha Mazzarello, Robyn Goldstein
Publikováno v:
SpringerPlus
While de-escalation of bisphosphonates from 4 to 12-weekly dosing has been shown to be clinically non-inferior to standard dosing, there is evidence the de-escalation is associated with increased bone turnover biomarkers. Here we evaluated the effect
Autor:
Georg F. Weber, Franz Hartung
Publikováno v:
SpringerPlus
Purpose: Despite a sizeable and continuously growing literature on osteopontin and cancer the molecule has not yet found entry into clinical diagnostics. Our identification of spliced variants that are more specific for cancer than the full-length tr
Publikováno v:
SpringerPlus
The humanized monoclonal antibody trastuzumab has been in routine use for chemotherapy for human epidermal growth factor receptor II (HER2)-positive breast cancer. A major adverse effect of trastuzumab is cardiotoxicity. Well-established biomarkers o